K2M Exercises Over-Allotment Option

Written by Laura Dyrda | June 11, 2014 | Print  |

Spine device company K2M closed on their initial public offering earlier this year and the IPO's underwriters exercised their over-allotment option, according to a company news release.

The underwriters exercised their option to purchase 1 million shares of common stock from the selling stakeholders at a price of $15 per share before underwriting discounts. The over-allotment option closed on June 10 and K2M will not receive any proceeds from the sale of these shares.

 

Pipar Jaffray & Co., Barclays Capital and Wells Fargo Securities acted as joint book-running managers for the offering. William Blair & Company and Cowen and Company acted as co-managers.

 

More Articles on Medical Devices:
5 Key Cost & Quality Findings on Spinal Fusion vs. coflex
Orthocell Launches IPO: 3 Key Facts
Behind the K2M IPO: CEO Eric Major Talks Strategy, Innovation & Future Financial Growth

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months